Advanced search
Publication Cover
Modern Rheumatology Volume 28, 2018 - Issue 3
Journal homepage
187
Views
10
CrossRef citations to date
0
Altmetric
Case report

Diffuse large B-cell lymphoma of the lacrimal sac arising from a patient with IgG4-related disease

Hidenori MarunakaDepartment of Otolaryngology, National Hospital Organization Okayama Medical Center, Okayama, Japan,
,
Yorihisa OritaDepartment of Otolaryngology, Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, Correspondence[email protected]
,
Tomoyasu TachibanaDepartment of Otolaryngology, Himeji Red Cross Hospital, Hyogo, Japan,
,
Kentaro MikiDepartment of Otolaryngology, Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan,
,
Takuma MakinoDepartment of Otolaryngology, Himeji Red Cross Hospital, Hyogo, Japan,
,
Tadashi YoshinoDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, and
,
Kazunori NishizakiDepartment of Otolaryngology, Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan,
&
Yasuharu SatoDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, and ;Division of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama, Japan
 show all
Pages 559-563 | Received 24 Aug 2015, Accepted 09 Dec 2015, Published online: 16 Feb 2016

References

  • Sato Y, Ohshima K, Ichimura K, Sato M, Yamadori I, Tanaka T, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58:465–70.
  • Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812–9.
  • Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;36:539–51.
  • Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22:414–8.
  • Hart PA, Law RJ, Dierkhising RA, Smyrk TC, Takahashi N, Chari ST. Risk of cancer autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014;43:417–21.
  • Uehara T, Ikeda S, Hamano H, Kawa S, Moteki H, Matsuda K, et al. A case of Mikulicz’s disease complicated by malignant lymphoma: a postmortem histopathological finding. Intern Med. 2012;51:419–23.
  • Oyama T, Takizawa J, Nakamura N, Aoki S, Aizawa Y, Abe H. Multifocal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: a case report. Jpn J Ophthalmol. 2011;55:304–6.
  • Takahashi N, Ghazale Ah, Smyrk TC, Mandrekar JN, Chari ST. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas. 2009;38:523–6.
  • Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, et al. Ocular adnexal lymphoma associated with IgG4 + chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159–67.
  • Ohno K, Sato Y, Ohshima K, Takata K, Miiyata-Takata T, Takeuchi M, et al. A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease. Sci Rep. 2015;5:13539.
  • Japanese study group of IgG4-related ophthalmic disease. A prevalence study of IgG4-related ophthalmic disease in Japan. Jpn J Ophthalmol. 2013;57:573–9.
  • Karagiannis P, Gilbert AE, Josephs DH, Ali N, Dodev T, Saul L, et al. IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest. 2013;123:1457–74.
  • Miki K, Orita Y, Sato Y, Noyama M, Fuji S, Domae S, et al. Mucosa-associated lymphoid tissue lymphoma of the thyroid with abundant IgG4-positive plasma cells. Auris Nasus Larynx. 2013;40:587–90.
  • Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol. 2012;67:297–305.
  • Gürcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol. 2009;9:10–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.